Lactation
0
Pipeline Programs
4
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
1 programInjected GLP-1 Receptor Agonists and Dual AgonistsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
Colorado TherapeuticsInjected GLP-1 Receptor Agonists and Dual Agonists
Providence TherapeuticsHeat exposure
Clinical Trials (2)
Total enrollment: 28 patients across 2 trials
Effects of GLP-1 RAs on Human Lactation Outcomes
Start: Jul 2026Est. completion: Jun 202818 patients
N/ARecruiting
The Impact of Acute Exercise in the Heat on Breast Milk Production and Composition in Lactating Women
Start: Jul 2025Est. completion: May 202610 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 28 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.